Nifty Pharma Index
NIFTY PHARMANifty Pharma Index
NIFTY PHARMAPrice Chart
Key Metrics
PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
39.78 | 5.85 | 0.61% |
Market Cap ShareM Cap Share | ConstituentsConstituents | ETFsETFs |
---|---|---|
3.69% | 20 | — |
About Index
Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.
Get more out of Tickertape, Go Pro!
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
Free float marketcap values in ₹ thousand cr.
Stocks | 1D change | Return attribution | Index weight | Free float marketcap | |
---|---|---|---|---|---|
NIFTY PHARMA 1D return-0.70% | 0.70% | -0.70% | 100.00% | ||
Abbott India Ltd0.71% Return attribution0.01% | 0.71% | 0.01% | 1.89% | 14.58 | |
Alkem Laboratories Ltd0.33% Return attribution0.01% | 0.33% | 0.01% | 2.88% | 22.21 | |
Aurobindo Pharma Ltd1.35% Return attribution-0.07% | 1.35% | -0.07% | 5.44% | 41.89 | |
Biocon Ltd1.40% Return attribution-0.03% | 1.40% | -0.03% | 2.08% | 16.03 | |
Zydus Lifesciences Ltd3.33% Return attribution-0.11% | 3.33% | -0.11% | 3.39% | 26.11 | |
Cipla Ltd0.49% Return attribution-0.06% | 0.49% | -0.06% | 11.57% | 89.14 | |
Dr Reddy's Laboratories Ltd0.75% Return attribution-0.07% | 0.75% | -0.07% | 9.95% | 76.64 | |
Divi's Laboratories Ltd0.10% Return attribution-0.01% | 0.10% | -0.01% | 9.00% | 69.32 | |
Glenmark Pharmaceuticals Ltd0.70% Return attribution-0.02% | 0.70% | -0.02% | 2.94% | 22.61 | |
Granules India Ltd1.27% Return attribution-0.01% | 1.27% | -0.01% | 0.96% | 7.38 | |
IPCA Laboratories Ltd0.07% Return attribution-0.00% | 0.07% | -0.00% | 2.49% | 19.21 | |
J B Chemicals and Pharmaceuticals Ltd0.11% Return attribution-0.00% | 0.11% | -0.00% | 1.71% | 13.21 | |
Laurus Labs Ltd4.12% Return attribution-0.09% | 4.12% | -0.09% | 2.15% | 16.57 | |
Lupin Ltd3.34% Return attribution-0.23% | 3.34% | -0.23% | 6.73% | 51.87 | |
Natco Pharma Ltd1.13% Return attribution-0.02% | 1.13% | -0.02% | 1.72% | 13.28 | |
Sanofi India Ltd0.25% Return attribution0.00% | 0.25% | 0.00% | 0.84% | 6.50 | |
Sun Pharmaceutical Industries Ltd0.26% Return attribution0.07% | 0.26% | 0.07% | 25.40% | 195.68 | |
Torrent Pharmaceuticals Ltd0.93% Return attribution-0.04% | 0.93% | -0.04% | 4.19% | 32.26 | |
Gland Pharma Ltd1.74% Return attribution-0.03% | 1.74% | -0.03% | 1.72% | 13.24 | |
Mankind Pharma Ltd0.07% Return attribution0.00% | 0.07% | 0.00% | 2.93% | 22.58 |
ETFs tracking this Index
Events
Dividends
Corp. Actions
Announcements
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash DividendGLENMARK
GLENMARKEx DateEx DateSep 13, 2024
Dividend/Share
₹2.50
Ex DateEx Date
Sep 13, 2024
Cash DividendNATCOPHARM
NATCOPHARMEx DateEx DateAug 23, 2024
Dividend/Share
₹3.00
Ex DateEx Date
Aug 23, 2024
Cash DividendGLAND
GLANDEx DateEx DateAug 16, 2024
Dividend/Share
₹20.00
Ex DateEx Date
Aug 16, 2024
Cash DividendJBCHEPHARM
JBCHEPHARMEx DateEx DateAug 14, 2024
Dividend/Share
₹6.75
Ex DateEx Date
Aug 14, 2024
Cash DividendALKEM
ALKEMEx DateEx DateAug 9, 2024
Dividend/Share
₹5.00
Ex DateEx Date
Aug 9, 2024
News & Opinions
Aurobindo Pharma arm receives EIR from USFDA for Andhra Unit; stock down 2%
22 hours ago•Business Standard
Endiya Partners leads AltiusHub’s $2.25 million fundraise
23 hours ago•Economic Times
Stock market update: Nifty Pharma index falls 0.36% in an upbeat market
1 day ago•Economic Times
Stock market update: Nifty Pharma index falls 0.28%
1 day ago•Economic Times
Granules India Ltd drops for fifth straight session
1 day ago•Business Standard
Stock market update: Nifty Pharma index advances 0.03% in an upbeat market
2 days ago•Economic Times
Benchmarks hit record highs, eyes on US Fed
2 days ago•Business Standard